Complications of hepatic chemoembolization

Seminars in Interventional Radiology

Volumn 23, Issue 2, 2006, Pages 119-125

  Clark, Timothy W I ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Complications; Hepatic chemoembolization; Hepatocellular carcinoma; Liver metastases

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CEFAZOLIN; CIPROFLOXACIN; CISPLATIN; DOXORUBICIN; ERYTHROMYCIN; GELATIN; INSULIN; IODINATED POPPYSEED OIL; LEVOFLOXACIN; METRONIDAZOLE; MITOMYCIN C; NEOMYCIN; OCTREOTIDE; PETHIDINE; PROTON PUMP INHIBITOR; SEROTONIN; SODIUM CHLORIDE; SUCRALFATE; VASODILATOR AGENT;

ABSCESS DRAINAGE; ACUTE KIDNEY FAILURE; ALOPECIA; ANEMIA; ANTIBIOTIC PROPHYLAXIS; ARTERY CATHETERIZATION; ARTERY DIAMETER; ARTERY INJURY; ARTERY SPASM; BACTEREMIA; BALLOON OCCLUSION; BILE DUCT OBSTRUCTION; BILOMA; BLOOD VESSEL INJURY; BONE MARROW SUPPRESSION; CHEMOEMBOLIZATION; CHOLECYSTITIS; DRUG CONTRAINDICATION; DUODENUM ULCER; FEVER; HEMATOMA; HEPATIC ARTERY; HUMAN; HYPERTENSION; INTESTINE PREPARATION; LEUKOPENIA; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER CHEMOEMBOLIZATION; LIVER FAILURE; LIVER METASTASIS; LIVER TUMOR; LUNG ABSCESS; LUNG EMBOLISM; MALAISE; MORBIDITY; NAUSEA; PAIN; PNEUMONIA; REVIEW; SEPSIS; SEROTONIN RELEASE; SPLEEN ABSCESS; STOMACH ULCER; SUBPHRENIC ABSCESS; THROMBOSIS; VARICOSIS; VASCULAR ACCESS; VOMITING;

EID: 33744502088     PISSN: 07399529     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-941442     Document Type: Review

References (39)

1. Hong K, Liapi E, Georgiades CS, Geschwind JF. Case-controlled comparison of a percutaneous collagen arteriotomy closure device versus manual compression after liver chemoembolization. J Vasc Interv Radiol 2005;16:339-345
2. Yoon DY, Park JH, Chung JW, Han JK, Han MC. Iatrogenic dissection of the celiac artery and its branches during transcatheter arterial embolization for hepatocellular carcinoma: outcome in 40 patients. Cardiovasc Intervent Radiol 1995;18:16-19
3. Covey AM, Brody LA, Maluccio MA, Getrajdman GI, Brown KT. Variant hepatic arterial anatomy revisited: digital subtraction angiography performed in 600 patients. Radiology 2002;224:542-547
4. Inaba Y, Arai Y, Matsueda K, Takeuchi Y, Aramaki T. Right gastric artery embolization to prevent acute gastric mucosal lesions in patients undergoing repeat hepatic arterial infusion chemotherapy. J Vasc Interv Radiol 2001;12:957-963
5. Nakamura H, Hashimoto T, Oi H, Sawada S, Furui S. Prevention of gastric complications in hepatic arterial chemoembolization. Balloon catheter occlusion technique. Acta Radiol 1991;32:81-82
6. Hirakawa M, Iida M, Aoyagi K, Matsui T, Akagi K, Fujishima M. Gastroduodenal lesions after transcatheter arterial chemo-embolization in patients with hepatocellular carcinoma. Am J Gastroenterol 1988;83:837-840
7. Leung DA, Goin JE, Sickles C, Raskay BJ, Soulen MC. Determinants of postembolization syndrome after hepatic chemoembolization. J Vasc Interv Radiol 2001;12:321-326
8. Kuroda C, Iwasaki M, Tanaka T, et al. Gallbladder infarction following hepatic transcatheter arterial embolization. Angiographic study. Radiology 1983;149:85-89
9. Chung JW, Park JH, Han JK, Choi BI, Kim TK, Han MC. Transcatheter oily chemoembolization of the inferior phrenic artery in hepatocellular carcinoma: the safety and potential therapeutic role. J Vasc Interv Radiol 1998;9:495-500
10. Arora R, Soulen MC, Haskal ZJ. Cutaneous complications of hepatic chemoembolization via extrahepatic collaterals. J Vasc Interv Radiol 1999;10:1351-1356
11. Yamaura K, Higashi M, Akiyoshi K, Itonaga Y, Inoue H, Takahashi S. Pulmonary lipiodol embolism during transcatheter arterial chemoembolization for hepatoblastoma under general anaesthesia. Eur J Anaesthesiol 2000;17:704-708
12. Kwok PC, Lam TW, Lam CL, Lai AK, Lo HY, Chan SC. Rare pulmonary complications after transarterial chemoembolisation for hepatocellular carcinoma: two case reports. Hong Kong Med J 2003;9:457-460
13. Chung JW, Park JH, Im JG, Han JK, Han MC. Pulmonary oil embolism after transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 1993;187:689-693
14. Tajima T, Honda H, Kuroiwa T, et al. Pulmonary complications after hepatic artery chemoembolization or infusion via the inferior phrenic artery for primary liver cancer. J Vasc Interv Radiol 2002;13:893-900
15. Brown KT. Fatal pulmonary complications after arterial embolization with 40-120-micro m tris-acryl gelatin microspheres. J Vasc Interv Radiol 2004;15:197-200
16. Kessler JM, Harini A, Hong K, Georgiades CS, Geschwind JF. Toxicity of transcatheter arterial chemoembolization for unresectable liver tumors. J Vasc Interv Radiol 2005;16: S54 (Abstract)
17. Civalleri D, Pellicci R, Decaro G, et al. Palliative chemoembolization of hepatocellular carcinoma with mitoxantrone, Lipiodol, and Gelfoam. A phase II study. Anticancer Res 1996;16:937-941
18. Kobayashi S, Nakanuma Y, Terada T, Matsui O. Postmortem survey of bile duct necrosis and biloma in hepatocellular carcinoma after transcatheter arterial chemoembolization therapy: relevance to microvascular damages of peribiliary capillary plexus. Am J Gastroenterol 1993;88:1410-1415
19. Kim W, Clark TW, Baum RA, Soulen MC. Risk factors for liver abscess formation after hepatic chemoembolization. J Vasc Interv Radiol 2001;12:965-968
20. Geschwind JF, Kaushik S, Ramsey DE, Choti MA, Fishman EK, Kobeiter H. Influence of a new prophylactic antibiotic therapy on the incidence of liver abscesses after chemoembolization treatment of liver tumors. J Vasc Interv Radiol 2002;13:1163-1166
21. Patel SS, Tuite CM, Mondschein JI, Soulen MC. Effectiveness of an aggressive antibiotic regimen for chemoembolization in patients with prior biliary intervention. J Vasc Interv Radiol 2005;16:S54 (Abstract)
22. Pitt HA, Zuidema GD. Factors influencing mortality in the treatment of pyogenic hepatic abscess. Surg Gynecol Obstet 1975;140:228-234
23. Pitt HA. Surgical management of hepatic abscesses. World J Surg 1990;14:498-504
24. Reed RA, Teitelbaum GP, Daniels JR, Pentecost MJ, Katz MD. Prevalence of infection following hepatic chemoembolization with cross-linked collagen with administration of prophylactic antibiotics. J Vasc Interv Radiol 1994;5:367-371
25. Tarazov PG, Polysalov VN, Prozorovskij KV, Grishchenkova IV, Rozengauz EV. Ischemic complications of transcatheter arterial chemoembolization in liver malignancies. Acta Radiol 2000;41:156-160
26. Cubiella J, Sans M, Llovet JM, et al. Pulmonary abscess as a complication of transarterial embolization of multinodular hepatocellular carcinoma. Am J Gastroenterol 1997;92:1942-1943
27. Wong E, Khardori N, Carrasco CH, Wallace S, Patt Y, Bodey GP. Infectious complications of hepatic artery catheterization procedures in patients with cancer. Rev Infect Dis 1991;13:583-586
28. Yokoi Y, Suzuki S, Sakaguchi T, et al. Subphrenic abscess formation following superselective transcatheter chemoembolization for hepatocellular carcinoma. Radiat Med 2002;20:45-49
29. Kono N, Nakanuma Y. Ultrastructural and immunohistochemical studies of the intrahepatic peribiliary capillary plexus in normal livers and extrahepatic biliary obstruction in human beings. Hepatology 1992;15:411-418
30. Berger DH, Carrasco CH, Hohn DC, Curley SA. Hepatic artery chemoembolization or embolization for primary and metastatic liver tumors: post-treatment management and complications. J Surg Oncol 1995;60:116-121
31. Huang YS, Chiang JH, Wu JC, Chang FY, Lee SD. Risk of hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma: predictive value of the monoethylglycinexylidide test. Am J Gastroenterol 2002;97:1223-1227
32. Chung JW, Park JH, Han JK, et al. Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization. Radiology 1996;198:33-40
33. Pentecost MJ, Daniels JR, Teitelbaum GP, Stanley P. Hepatic chemoembolization: safety with portal vein thrombosis. J Vasc Interv Radiol 1993;4:347-351
34. Spahr L, Becker C, Pugin J, Majno PE, Hadengue A. Acute portal hemodynamics and cytokine changes following selective transarterial chemoembolization in patients with cirrhosis and hepatocellular carcinoma. Med Sci Monit 2003;9: CR383-CR388
35. Sato M, Yamada R, Uchida B, Hedgepeth P, Rosch J. Effects of hepatic artery embolization with Lipiodol and gelatin sponge particles on normal swine liver. Cardiovasc Intervent Radiol 1993;16:348-354
36. Sakamoto I, Aso N, Nagaoki K, et al. Complications associated with transcatheter arterial embolization for hepatic tumors. Radiographics 1998;18:605-619
37. Huo TI, Wu JC, Lee PC, Chang FY, Lee SD. Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective study. Liver Int 2004;24:210-215
38. Kim MJ, Lee SW, Kim GA, Song JH. Acute renal failure after transarterial chemoembolization progressing to chronic renal failure in hepatocellular carcinoma. Nephrol Dial Transplant 2000;15:741-742
39. Balestrero LM, Beaver CR, Rigas JR. Hypertensive crisis following meperidine administration and chemoembolization of a carcinoid tumor. Arch Intern Med 2000;160:2394-2395